| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.5M | +32.8% |
| SG&A Expense | $1.2M | -30.0% |
| Operating Income | -$10.9M | -154.5% |
| Net Income | -$10.9M | -153.5% |
| EPS (Basic) | -$0.41 | -356.2% |
| EPS (Diluted) | -$0.41 | -356.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.6M | +1211.2% |
| Current Assets | $4.7M | +1093.0% |
| Total Assets | $7.4M | +225.6% |
| Current Liabilities | $3.1M | +137.8% |
| Total Liabilities | $3.1M | +134.1% |
| Stockholders' Equity | $4.3M | +354.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.4M | +8.2% |
| Investing Cash Flow | -$362K | -36.6% |
| Financing Cash Flow | $7.0M | +134.3% |